| |
|
|
|
Redhill Biophrma ADR  
|
|
7.78 -0.59 (-0.07%) |
08-14 16:00 |
|
Open: |
8.37 |
Pre close: |
8.37 |
Target:
|
10.04 
|
|
High: |
8.4 |
Low: |
7.77 |
Resistance:
|
8.60
10.17
|
|
Volume: |
397,946 |
Market Cap: |
274M |
Support:
|
6.06
5.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.82
|
MACD |
MACD(12,26):
|
0.46 |
|
MA(20): |
7.68  |
Signal(12,26,9): |
0.39 |
|
MA(100): |
6.90 |
Stochastic Oscillator |
%K(14,3):
|
53.18 |
|
MA(250): |
6.43 |
%D(3): |
65.12 |
|
Average Volume(K) |
3-Month: |
36798
|
52-Week |
High:
|
10.17 |
|
10-Days: |
61488 |
Low: |
3.26 |
|
RSI |
RSI(14):
|
50.65 |
Change(%): |
12.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.580 |
Return on Equity (ttm) |
-116.0 |
Shares Out. (M) |
35.27 |
|
EPS Est. Current Year |
-2.390 |
Return on Assets (ttm) |
-31.1 |
Shares Float (M) |
20.84 |
|
EPS Est. Next Year |
-0.540 |
PEG Ratio |
0.00 |
% Held by Insiders |
15.37 |
|
EPS Est. Next Quarter |
-0.620 |
Qtrly Rev. Growth |
-39.2 |
% Held by Institutions |
20.91 |
|
Forward EPS |
1.700 |
Gross Profit (p.s.) |
0.114 |
Shares Short (K) |
1800 |
|
Book Value (p.s.) |
1.240 |
EBITDA (p.s.) |
-1.409 |
P/E |
-4.92 |
|
Sales Per Share |
0.159 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-43.84 |
P/S |
48.91 |
|
Operating Margin |
-894.62 |
Levered Free Cash Flow
(M) |
-25.54 |
P/CF |
-6.26 |
|
|
|
|
|
|
